USX:FMI - Foundation Medicine Inc (USD 137) Foundation Medicine Inc
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist
   


Yahoo Finance
Note: This stock seems to be inactive

USD 137.0    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

31 Jul 2018


Overview

31 Jul 2018

Day Change: 0 (0%)

52 Wk Range: 33.2 - 137.2

Day's Range: 137.0 - 137.0

Last Volume: 2,500

Current Yield: 0%

Projected Yield: 0%

Open: USD 137.0

31 Jul 2019

Metric FMI S.Median
Beta NA 0.72
VaR NA 16.91
E.Shortfall NA 23.3
Liquidity NA 71.96K

Fundamental

31 Jul 2018

PE: -35.908

Market Cap: 5.1B

Price Over Book: -595.443

Price Over Sales: 25.23

Return On Assets: -73.2%

Return On Equity: 1.7K%

Price Over NAV: [Friends Only]

General

CEO: Troy Cox

Headquarters: CAMBRIDGE

Employees: 535

Sector: Health Technology

Industry: Medical Specialties

Useful Links
Homepage

Description

Foundation Medicine, Inc. provides various molecular information products in the United States. The company's molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic information about each patient's individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted oncology therapies. It provides clinical products, such as FoundationOne for solid tumors; FoundationOne Heme for blood-based cancers, or hematologic malignancies, including leukemia, lymphoma, and myeloma, as well as sarcomas and pediatric cancers; Foundation Assay for Circulating Tumor; FoundationFocus CDxBRCA, a diagnostic assay to aid in identifying women with ovarian cancer. The company also offers FoundationCORE, a knowledgebase to publish scientific and medical advances, and foster relationships throughout the oncology community. In addition, it has strategic collaboration agreements with WuXi PharmaTech Inc.; F. Hoffmann-La Roche Ltd.; and Genentech, Inc. The company was founded in 2009 and is headquartered in Cambridge, Massachusetts. Foundation Medicine, Inc. is a subsidiary of Roche Holdings, Inc.